Advertisement

Index by author

May 01, 1989; Volume 35,Issue 5

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Riddick, D S
1. You have access
  Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver.
  D S Riddick, S S Park, H V Gelboin and G S Marks
  
  Molecular Pharmacology May 1989, 35 (5) 626-634;
Safe, S
1. You have access
  Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies.
  M Harris, T Zacharewski, B Astroff and S Safe
  
  Molecular Pharmacology May 1989, 35 (5) 729-735;
Schols, D
1. You have access
  5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
  J Balzarini, A Van Aerschot, R Pauwels, M Baba, D Schols, P Herdewijn and E De Clercq
  
  Molecular Pharmacology May 1989, 35 (5) 571-577;
Seiler, M P
1. You have access
  Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
  M P Seiler, R Markstein, M D Walkinshaw and J J Boelsterli
  
  Molecular Pharmacology May 1989, 35 (5) 643-651;
Shoshani, I
1. You have access
  Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
  R A Johnson, S M Yeung, D Stübner, M Bushfield and I Shoshani
  
  Molecular Pharmacology May 1989, 35 (5) 681-688;
Skolnick, P
1. You have access
  Ultraviolet irradiation selectively disrupts the gamma-aminobutyric acid/benzodiazepine receptor-linked chloride ionophore.
  G Evoniuk, E J Moody and P Skolnick
  
  Molecular Pharmacology May 1989, 35 (5) 695-700;
Stubner, D
1. You have access
  Cation and structural requirements for P site-mediated inhibition of adenylate cyclase.
  R A Johnson, S M Yeung, D Stübner, M Bushfield and I Shoshani
  
  Molecular Pharmacology May 1989, 35 (5) 681-688;
Van Aerschot, A
1. You have access
  5-Halogeno-3'-fluoro-2',3'-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3'-fluoro-2',3'-dideoxy-5-chlorouridine.
  J Balzarini, A Van Aerschot, R Pauwels, M Baba, D Schols, P Herdewijn and E De Clercq
  
  Molecular Pharmacology May 1989, 35 (5) 571-577;
Walkinshaw, M D
1. You have access
  Characterization of dopamine receptor subtypes by comparative structure-activity relationships: dopaminomimetic activities and solid state conformation of monohydroxy-1,2,3,4,4a,5,10,10a-octahydrobenz[g]quinolines and its implications for a rotamer-based dopamine receptor model.
  M P Seiler, R Markstein, M D Walkinshaw and J J Boelsterli
  
  Molecular Pharmacology May 1989, 35 (5) 643-651;
Weber, E
1. You have access
  Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site.
  R A Lester, M L Quarum, J D Parker, E Weber and C E Jahr
  
  Molecular Pharmacology May 1989, 35 (5) 565-570;